Class 2 integron with a novel cassette array in a Burkholderia cenocepacia isolate [1]

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 10, 2005, Pages 4418-4420

  Ramírez, María Soledad ^a   Vargas, Liliana Jordá ^a   Cagnoni, Viviana ^b   Tokumoto, Marta ^b   Centrón, Daniela ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; COTRIMOXAZOLE; MEROPENEM;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; BURKHOLDERIA; BURKHOLDERIA CENOCEPACIA; CASE REPORT; CYSTIC FIBROSIS; GENE CASSETTE; GENE REARRANGEMENT; HUMAN; INTEGRON; LETTER; NONHUMAN; NUCLEOTIDE SEQUENCE; OPPORTUNISTIC INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRANSPOSON;

ADOLESCENT; BURKHOLDERIA CEPACIA COMPLEX; CYSTIC FIBROSIS; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; GENES, BACTERIAL; GENOME, BACTERIAL; HUMANS; INTEGRASES; INTEGRONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE ANALYSIS, DNA; SPUTUM;

EID: 25844476058     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.10.4418-4420.2005     Document Type: Letter

References (11)

1. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing, 14th informational supplement. CLSI document M100-S15. Clinical and Laboratory Standards Institute, Wayne, Pa.
2. Crowley, D., M. Daly, B. Lucey, P. Shine, J. J. Collins, B. Cryan, J. E. Moore, P. Murphy, G. Buckley, and S. Flanning. 2002. Molecular epidemiology of cystic fibrosis-linked Burkholderia cepacia complex isolates from three national referral centres in Ireland. J. Appl. Microbiol. 92:992-1004.
3. Hansson, K., L. Sundstrom, A. Pelletier, and P. Roy. 2002. IntI2 integron integrase in Tn7. J. Bacteriol. 184:1712-1721.
4. Henry, D. A., E. Mahenthiralingam, P. Vandamme, T. Coenye, and D. P. Speert. 2001. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J. Clin. Microbiol. 37:1004-1007.
5. Lévesque, C., L. Piché, C. Larose, and P. H. Roy. 1995. PCR mapping of integrons reveals novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:185-191.
6. Lewin, C., C. Doherty, and J. Govan. 1993. In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia. Antimicrob. Agents Chemother. 37:123-125.
7. NCCLS. 2003. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. NCCLS document M7-A6. NCCLS, Wayne, Pa.
8. Orman, B. E., S. A. Pineiro, S. Arduino, M. Galas, R. Melano, M. I. Caffer, D. O. Sordelli, and D. Centrón. 2002. Evolution of multiresistance in non-typhoid Salmonella serovars from 1984 to 1998 in Argentina. Antimicrob. Agents Chemother. 46:3963-3970.
9. Petrucca, A., P. Cipriani, P. Valenti, D. Santapaola, C. Cimmino, G. L. Scoarughi, I. Santino, S. Stefani, R. Sessa, and M. Nicoletti. 2003. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center. Res. Microbiol. 154:491-498.
10. Urban, T. A., A. Griffith, A. M. Torok, M. E. Smolkin, J. L. Burns, and J. B. Golberg. 2004. Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation. Infect. Immun. 72:5126-5134.
11. Waddell, C. S., and N. L. Craig. 1988. Tn7 transposition: two transposition pathways directed by five Tn7-encoded genes. Genes Dev. 2:137-149.